IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 171 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.14 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,753,000 | +19.1% | 55,372 | +23.8% | 0.01% | -22.2% |
| Q3 2020 | $1,472,000 | -84.0% | 44,724 | -86.6% | 0.01% | -85.2% |
| Q2 2020 | $9,173,000 | +253.1% | 334,172 | +285.0% | 0.06% | +205.0% |
| Q1 2020 | $2,598,000 | +960.4% | 86,803 | +881.0% | 0.02% | +1900.0% |
| Q4 2019 | $245,000 | -95.2% | 8,848 | -95.8% | 0.00% | -96.9% |
| Q2 2019 | $5,153,000 | -14.1% | 210,174 | -66.7% | 0.03% | +52.4% |
| Q1 2019 | $6,002,000 | +895.4% | 630,898 | +826.0% | 0.02% | +250.0% |
| Q4 2018 | $603,000 | -87.4% | 68,128 | -84.0% | 0.01% | -62.5% |
| Q3 2018 | $4,796,000 | -30.3% | 426,364 | -20.7% | 0.02% | -59.0% |
| Q2 2018 | $6,882,000 | -75.7% | 537,668 | -68.0% | 0.04% | -72.5% |
| Q1 2018 | $28,375,000 | +30742.4% | 1,678,971 | +12628.2% | 0.14% | +14100.0% |
| Q2 2017 | $92,000 | – | 13,191 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |